Elisabeth Nagy

Elisabeth Nagy

Auto-generated profile, based on publicly available information

Elisabeth Nagy

Institute of Medical Microbiology, Faculty of Medicine, University of Szeged, Szeged, Hungary

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
ENE. Nagy
E. Nagy
Lyudmila BoyanovaLyudmila Boyanova
Lyudmila Boyanova
UJU.S. Justesen
U.S. Justesen

1 April 2013 in Anaerobe
Verified
Journal Article
Closed access
ENElisabeth Nagy
Elisabeth Nagy
EUEdit Urbán
Edit Urbán
SBSimone Becker
Simone Becker
MKMarkus Kostrzewa
Markus Kostrzewa
AVAndrea Vörös
Andrea Vörös
INIstván Nagy
István Nagy

1 February 2015 in Anaerobe
Verified
Journal Article
Closed access
ENElisabeth Nagy
Elisabeth Nagy
UJUlrik Stenz Justesen
Ulrik Stenz Justesen
ZEZsuzsa Eitel
Zsuzsa Eitel
EUEdit Urbán
Edit Urbán
EIESCMID Study Group on Anaerobic Infection
ESCMID Study Group on Anaerobic Infection


27 April 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
ZBZain Baaity
Zain Baaity
FLFriederike D. von Loewenich
Friederike D. von Loewenich
ENElisabeth Nagy
Elisabeth Nagy
László OroszLászló Orosz
László Orosz
Katalin BuriánKatalin Burián
Katalin Burián
SJSóki József
Sóki József
Carbapenem-resistant Bacteroides fragilis strains usually emerge by an insertion sequence (IS) jump into the upstream region of the cfiA carbapenemase gene. However, intermediate or fully resistant cfiA-positive strains also exist. These do not have such IS element activations, but usually have heterogeneous resistance (HR) phenotypes, as detected by a disc diffusion or gradient tests. Heteroresistance is a serious antibiotic resistance problem, whose molecular mechanisms are not fully understood. We aim to characterize HR and investigate diagnostic issues in the set of cfiA-positive B. fragilis strains using phenotypic and molecular methods. Of the phenotypic methods used, the population analysis profile (PAP) and area under curve (AUC) measurements were the best prognostic markers for HR. PAP AUC, imipenem agar dilution and imipenemase production corresponded well with each other. We also identified a saturation curve parameter (quasi-PAP curves), which correlated well with these phenotypic traits, implying that HR is a stochastic process. The genes, on a previously defined ‘cfiA element’, act in a complex manner to produce the HR phenotype, including a lysine-acetylating toxin and a lysine-rich peptide. Furthermore, imipenem HR is triggered by imipenem. The two parameters that most correlate with the others are imipenemase production and ‘GNAT’ expression, which prompted us to suspect that carbapenem heteroresistance of the B. fragilis strains is stochastically regulated and is mediated by the altered imipenemase production.

31 August 2021 in Journal of Medical Microbiology
Verified
Journal Article
Open access
SJSóki József
Sóki József
AKAnikó Keszőcze
Anikó Keszőcze
INIstván Nagy
István Nagy
KBKatalin Burián
Katalin Burián
ENElisabeth Nagy
Elisabeth Nagy
Introduction. There are several β-lactamase genes described for Bacteroide s strains, of which cepA and cfiA are specific for Bacteroides fragilis and define two genetic divisions. The expression and phenotypic effects of these genes are usually regulated by insertional activation. Hypotheses/Gap Statement. Information is lacking about how cepA is regulated for most of the B. fragilis strains and whether there could be a genetic element for it. Aim. We aimed to investigate the molecular background of ampicillin (and other β-lactam) resistance among Bacteroides strains as mediated mainly by cepA and also to find a genetic element for it as known for cfiA. Methodology. Various PCR methods were used for β-lactamase-resistance gene and insertion sequence (IS) element detection in 42 Bacteroides strains. β-Lactamase activity measurements and antimicrobial-susceptibility testing using agar dilution were also applied. Further molecular experiments involved sequencing, gene targeting, Southern blotting and bioinformatic analyses. Results. We found that high antibiotic resistance and β-lactamase levels are brought about by insertional activation of the cepA gene or by similar or dissimilar activation of cfxA or cfiA, or by the newly described pbbA genes. Non-activated cepA genes produced low levels of specific β-lactamase activities that did not correlate with ampicillin resistance. We found a genetic element for cepA and another region close to it that are characteristic for division I B. fragilis strains, which are replaced by other sequences in division II B. fragilis strains. Conclusion. cepA usually is not activated by IS elements and usually produces low β-lactamase activities that do not correlate with the ampicillin MICs; therefore, it probably involves some non-β-lactamase-mediated resistance mechanism(s). pbpA is a newly described, effective β-lactamase gene that is located on a plasmid, and cepA resides on a well-defined chromosomal segment that is mutually replaced in division II B. fragilis strains. This latter finding demonstrates the genetic dichotomy of cepA–cfiA in B. fragilis and requires further investigation.